Senior Executives Highlight Mergers and Acquisitions and Expansions at DCAT Week ’18
By

At the DCAT Member Company Announcement Forum, held during DCAT Week, senior executives from member companies of the Drug, Chemical & Associated Technologies Association (DCAT) provided the latest major news from their companies impacting the pharmaceutical manufacturing value chain. So what did they report?

The executives highlighted key strategic activity, including mergers and acquisitions (M&A), post-M&A integration, and manufacturing expansions. Lonza, DowDuPont, Catalent, Novasep, CordenPharma, Piramal Pharma Solutions, SK biotek, Biocon, Procos, Nosco, AB BioTechnologies, and PolyCrystalLine were among the companies taking the podium to provide their latest developments.

The executives highlighted developments to expand active pharmaceutical ingredient (API) development and manufacturing (both small molecules and biologics), drug-product development and manufacturing (both solid dosage and parenteral drugs), and packaging. A roundup of these developments are provided in the stories below.

Lonza Updates Integration of $5.5-Billion Acquisition of Capsugel

DowDuPont Outlines Integration of Combined Company, Including Excipients Business

Catalent Updates Integration of $950-Million Acquisition of Cook Pharmica

Novasep Announces $65-Million Investment in Biologics

CordenPharma Outlines Integration of Former Pfizer API Facility

Piramal Pharma Solutions CEO Outlines Expansion Plans

SK biotek Outlines Integration of Former BMS API Manufacturing Facility

Biocon COO Highlights Company’s Growth Strategy

Procos CEO Outlines Expansion for High-Potency Manufacturing

Nosco President Discusses Company’s Growth Strategy in Wake of Two Key Acquisitions

AB BioTechnologies CEO Announces $12-Million Expansion

PolyCrystalLine CEO Announces Expansion of Solid-State Chemistry Capabilities

Leave a Reply

Your email address will not be published.

Recent Feature Articles

Does the Metaverse Have Potential in Pharma?
By

By
The metaverse is expected to have far-reaching applications in sectors such as healthcare, manufacturing, education/job training, and communications. What is the metaverse exactly, and what technologies and functions are in play?

Tracking Pharma Growth: Leading Therapeutic Sectors
By

By
Oncology continues to be the leading therapeutic sector in the global bio/pharma market on a value basis and in growth rates. What do the numbers show, and what other therapeutic sectors rank high in growth prospects?

CDMO Outsourcing Trends: Cell and Gene Therapies
By

By
Facing limited industry capacity, both large and small CDMOs continue to expand capacity for cell and gene therapies, but will demand for outsourced services by bio/pharma companies stay strong in the near term? 

Rising Energy & Raw Materials Costs: When Is Relief Coming?
By

By
Inflationary pressures, in the form of higher energy, raw materials, and shipping costs, have tightened margins across all industries, including the bio/pharma industry. When will relief be on the way?